STOCK TITAN

Solventum (NYSE: SOLV) CIO receives 12,716 RSUs as 1,731 shares withheld for tax

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Solventum Corp Chief Information Officer Amy Landucci reported equity compensation activity involving restricted stock units and common shares. On March 5, 2026, she was granted 12,716 Restricted Stock Units (RSUs), each representing a right to receive one share of Class A common stock upon settlement, vesting in three equal annual installments.

On March 6, 2026, 3,795 RSUs were converted into 3,795 shares of common stock, and 1,731 common shares at $69.41 per share were disposed of to cover tax obligations, described as a tax-withholding disposition. After these transactions, her directly held common stock position was 37,483 shares, with 7,593 RSUs remaining from the earlier award.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Landucci Amy

(Last) (First) (Middle)
2510 CONWAY AVE.
3M CENTER BLDG. 275-6W

(Street)
MAPLEWOOD MN 55144

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Solventum Corp [ SOLV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Information Officer
3. Date of Earliest Transaction (Month/Day/Year)
03/05/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/06/2026 M 3,795 A $0 39,214 D
Common Stock 03/06/2026 F 1,731 D $69.41 37,483 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 03/05/2026 A 12,716 (2) (2) Common Stock 12,716 $0 12,716 D
Restricted Stock Units (1) 03/06/2026 M 3,795 (2) (2) Common Stock 3,795 $0 7,593 D
Explanation of Responses:
1. Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement.
2. The RSUs shall fully vest in three tranches, with one-third vesting on each of the first, second and third anniversaries of the grant date, subject to continued service through the vesting date.
Remarks:
/s/Megan Bombick, attorney-in-fact for Amy Landucci 03/09/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Solventum (SOLV) CIO Amy Landucci report?

Amy Landucci reported an RSU grant, an RSU conversion, and a tax-related share disposition. She received 12,716 RSUs, converted 3,795 RSUs into common shares, and had 1,731 shares withheld at $69.41 each to satisfy tax obligations.

How many Solventum (SOLV) RSUs were granted to Amy Landucci?

Amy Landucci received a grant of 12,716 Restricted Stock Units. Each RSU represents a contingent right to receive one share of Solventum’s Class A common stock, subject to future vesting conditions and continued service with the company through each vesting date.

What are the vesting terms of Amy Landucci’s new Solventum (SOLV) RSUs?

The RSUs vest in three installments over three years. One-third of the 12,716 RSUs vests on each of the first, second, and third anniversaries of the grant date, provided Amy Landucci continues her service with Solventum through each vesting date.

Did Amy Landucci sell Solventum (SOLV) shares in the open market?

The filing describes a tax-withholding disposition rather than an open-market sale. On March 6, 2026, 1,731 common shares at $69.41 per share were delivered to cover tax liability related to the RSU share delivery, not a discretionary stock sale.

How many Solventum (SOLV) common shares does Amy Landucci hold after these transactions?

After the reported transactions, Amy Landucci directly holds 37,483 Solventum common shares. This reflects the RSU conversion of 3,795 shares and the tax-withholding disposition of 1,731 shares, as disclosed in the filing’s post-transaction ownership figures.

How many Solventum (SOLV) RSUs remain outstanding for Amy Landucci after the exercise?

Following the March 6, 2026 RSU conversion, Amy Landucci has 7,593 Restricted Stock Units reported as outstanding. These remaining RSUs continue to represent contingent rights to receive common shares, subject to the vesting schedule and ongoing service requirements.
Solventum Corporation

NYSE:SOLV

View SOLV Stock Overview

SOLV Rankings

SOLV Latest News

SOLV Latest SEC Filings

SOLV Stock Data

11.73B
147.25M
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
ST. PAUL